cancer pain News
Most Popular cancer pain Story
Cephalon takes heat for off-label narcotic promotion
Connecticut Attorney General Richard Blumenthal has determined that Cephalon "engaged in questionable practices" to increase sales of the narcotic painkiller lollipop Actiq. The drug, which is FDA-approved only for use in treating cancer pain, is widely prescribed for conditions such as migraines and backache as well. With a growing number of patients becoming addicted to Actiq, which contains fentanyl, government regulators and physicians were concerned that marketing tactics were …
... Read more...Latest Headlines
- April 8, 2008
- February 6, 2008
- November 20, 2006
- October 10, 2006
- September 26, 2006
- September 4, 2006
- June 29, 2006
- March 5, 2006
- January 3, 2006
- July 18, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
